Fredrik B Thoren, Örjan Strannegård. Show Affiliations »
Abstract
Mesh： See more » Antineoplastic Agents/therapeutic useChemotherapy, AdjuvantDisease-Free SurvivalFollow-Up StudiesHumansInterferon alpha-2Interferon-alpha/therapeutic useMelanoma/drug therapyMelanoma/mortalityMelanoma/prevention & controlRandomized Controlled Trials as TopicRecombinant ProteinsSecondary PreventionSkin Neoplasms/drug therapySurvival AnalysisTime Factors
Substances： See more » Antineoplastic AgentsInterferon alpha-2Interferon-alphaRecombinant Proteins
Year: 2011 PMID： 21536217 DOI： 10.1016/S1470-2045(11)70107-3
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316